Acadia Pharmaceuticals Grants Equity Awards to New Hires Under Nasdaq Rule 5635(c)(4) Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to…
Manitoba Bioscience Association Backs Government Plan to Boost Research and Clinical Trials Bioscience Association Manitoba (BAM) has voiced strong support for a major new initiative from the Manitoba government aimed…
ISS Backs Glass Lewis in Supporting SINOVAC’s Current Board, Rejects Former Slate Ahead of Special Meeting SINOVAC Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced…
InnoCare Secures IND Approval in China for B7-H3-Targeted ADC ICP-B794 to Advance Solid Tumor Therapies InnoCare Pharma a leading biopharmaceutical company dedicated to developing innovative treatments for cancer and autoimmune…
Biotech Executives and Investors Urge FDA to Preserve Access to Mifepristone Amid Legal Uncertainty A group of leading biotechnology executives, investors, and scientific experts are urging the U.S. Food and…
Regeneron Secures FDA Accelerated Approval for Lynozyfic in Multiple Myeloma, Eyes Differentiation Despite Market Head Start by Rivals In a bid to strengthen its oncology portfolio, Regeneron Pharmaceuticals announced Wednesday…
Health Secretary Robert F. Kennedy Jr. Endorses Broader RSV Vaccine Use, Following Guidance from Former ACIP Panel Despite ousting the Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel…
Stallergenes Greer Appoints CEOLIA as New Promotional Partner for Actair® in Japan, Concluding 13-Year Collaboration with Shionogi Stallergenes Greer, a global leader in allergen immunotherapy, has announced a strategic transition…
WHO Concludes Participation in Major Global Nuclear Emergency Simulation The World Health Organization (WHO) has successfully concluded its role in a high-stakes, 36-hour nuclear emergency simulation exercise organized by the…
CroíValve Awarded €12.5M in Horizon Europe EIC Accelerator Funding to Advance Novel Treatment for Tricuspid Regurgitation CroíValve, a Dublin-based medical device company committed to transforming the treatment of tricuspid regurgitation…
Comprehensive Report Reveals Key Trends in Gynecology Collaboration and Licensing Deals from 2016 to 2025 Gynecology Collaboration and Licensing Deals report offers a deep dive into the evolving landscape of…
Synedgen Appoints Dr. Laura Saward as CEO and Dr. Kenton Gregory as CMO Amid Strategic Growth Synedgen, Inc., a biotechnology company pioneering treatments based on human glycobiology, has announced significant…